Citation Impact
Citing Papers
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
2016
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
2010
Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy
2012
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
2012
Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
2010
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
2016
Hallmarks of Cancer: The Next Generation
2011 Standout
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
2010
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release
2011
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Necroptosis and its role in inflammation
2015 StandoutNature
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
2016
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer
2010
Nucleotide signalling during inflammation
2014 StandoutNature
Extracellular adenosine triphosphate and adenosine in cancer
2010
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
2015
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
2014
Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer
2012
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
2013
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Cancer drug resistance: an evolving paradigm
2013 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Stimulation of anti-tumor immunity by photodynamic therapy
2010
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Nasopharyngeal carcinoma
2019 Standout
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
2013
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Viral strategies for the evasion of immunogenic cell death
2010
Inducers of immunogenic cancer cell death
2013
CD73: a potent suppressor of antitumor immune responses
2012
Chemoimmunotherapy: reengineering tumor immunity
2013
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
2012
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
2013
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
2016
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Inflammasomes in carcinogenesis and anticancer immune responses
2012
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
2012
Immune parameters affecting the efficacy of chemotherapeutic regimens
2011
Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival
2011
Going viral with cancer immunotherapy
2014
Cell death assays for drug discovery
2011
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
2016
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
ATP is released from autophagic vesicles to the extracellular space in a VAMP7-dependent manner
2012
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
2009
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
2013
Exploiting Intrinsic Nanoparticle Toxicity: The Pros and Cons of Nanoparticle-Induced Autophagy in Biomedical Research
2014
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
2014
Immune checkpoint modulation: Rational design of combination strategies
2015
Desirable cell death during anticancer chemotherapy
2010
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
2016
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features
2010
Mouse models in oncoimmunology
2016
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
2012
Immune microenvironments in solid tumors: new targets for therapy
2011
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
2012
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas
2011
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Combination cancer immunotherapies tailored to the tumour microenvironment
2015
Tumor microenvironment is multifaceted
2011
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation
2011
Microbiota: a key orchestrator of cancer therapy
2017
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
2014
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
The secret ally: immunostimulation by anticancer drugs
2012
Molecular mechanisms of ATP secretion during immunogenic cell death
2013
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
2013
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
2016
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Combinatorial Strategies for the Induction of Immunogenic Cell Death
2015
Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells
2011
A Mechanism of Release of Calreticulin from Cells During Apoptosis
2010
Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma
2010
The Tumor-Immune Microenvironment and Response to Radiation Therapy
2010
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Activation of Macrophages by P2X7-Induced Microvesicles from Myeloid Cells Is Mediated by Phospholipids and Is Partially Dependent on TLR4
2010
Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody
2011
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
2011 Science
Recent Developments in Cancer Vaccines
2011
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
2011
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
High hydrostatic pressure induces immunogenic cell death in human tumor cells
2014
Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer
2010
Immunotherapy for Colorectal Cancer
2017
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Endoplasmic Reticulum Stress in Immunity
2014
Photosensitizer Nanodot Eliciting Immunogenicity for Photo‐Immunologic Therapy of Postoperative Methicillin‐Resistant Staphylococcus aureus Infection and Secondary Recurrence
2021
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
2011
Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinoma
2012
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
2021 StandoutNobel
Innate Immune Recognition of Cancer
2015
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
2019 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
2010
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
2016
Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy
2016
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
2009
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
2015
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91
2012
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8 + T cells
2015 Science
Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
2014
Proapoptotic Chemotherapeutic Drugs Induce Noncanonical Processing and Release of IL-1β via Caspase-8 in Dendritic Cells
2013
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
2012
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
2015
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
2013
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Metronomic chemotherapy and immunotherapy in cancer treatment
2017
Works of F. Schlemmer being referenced
Immunogenic cancer cell death: a key-lock paradigm
2008
Disruption of the PP1/GADD34 complex induces calreticulin exposure
2009
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
2010
Immunogenic cell death modalities and their impact on cancer treatment
2009
Lysyl tRNA synthetase is required for the translocation of calreticulin to the cell surface in immunogenic death
2010
Surface‐exposed calreticulin in the interaction between dying cells and phagocytes
2010
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
2011
Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome
2019
Chemotherapy induces ATP release from tumor cells
2009
Viral subversion of immunogenic cell death
2009
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8
2013
Loss-of-function alleles ofP2RX7andTLR4fail to affect the response to chemotherapy in non-small cell lung cancer
2012
Immunogenic death of colon cancer cells treated with oxaliplatin
2009
In vivo depletion of T lymphocyte-specific transcription factors by RNA interference
2010